MintNeuro raises $5M to scale chips purpose-built for neural devices
MintNeuro, an Imperial College London spinout developing specialised chips for neural devices from implants to wearables, has raised $5 million to drive its commercial scale-up. The company is develop...
MintNeuro, a spinout from Imperial College London, has secured $5 million in funding to accelerate the commercialization of chips specifically designed for neural devices. These chips aim to bridge the gap between generic components and custom chip development, which has historically been a challenge as neurotechnology progresses from research to clinical and commercial applications.
The investment round was spearheaded by Odyssey Ventures, with additional backing from 33East, JSK Investments, JSK Ventures, and Alumni Ventures. Notably, Empirical Ventures, Jumpspace Ventures, and early investors also participated, along with returning investment from Empirical Ventures and Jumpspace Ventures.
MintNeuro has already achieved significant milestones, including delivering working silicon chips and integrating with key partners such as Motif Neurotech and Amber Therapeutics. Earlier this year, the company announced a multi-year supply agreement with Motif, which will provide chips for their minimally invasive neurostimulator, initially intended for treatment-resistant depression.
MintNeuro's modular semiconductor platform enables core functions such as neural sensing, signal processing, and stimulation. This allows for the development of smaller, lower-power devices and more integrated closed-loop interfaces with the nervous system. The architecture is designed to streamline these functions at the system level, making it easier for developers to incorporate MintNeuro's technology into various neural devices, including brain-computer interfaces (BCIs), neuromodulation systems, sensory prostheses, and bioelectronic medicines.
With this latest funding, MintNeuro will expand its engineering and commercial teams, bring its products to market, support customers in adopting its chips, and expand its presence in both the US and global markets. Founding partner Michelle Robson of Odyssey Ventures expressed her confidence in MintNeuro, stating that the company has the technology, market pull, and ambition to become a globally significant semiconductor company, and they are proud to support this exceptional team as they scale from the UK into international markets.
Rewritten by urgent.news; may contain errors — check the original.
Source: tech.eu